TER Stock Analysis: Teradyne | NASDAQ
Semiconductor Equipment & Materials | NASDAQ, USA | Market Cap: 48.972m USD | 12M Return: 42.9% | US8807701029 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 1.12B
EPS Trend: 84.8%
Qual. Beats: 5
Rev. Trend: 86.2%
Qual. Beats: 0
Warnings
Tailwinds
Seasonality 11.7 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Teradyne, Inc. (NASDAQ: TER) is a U.S.-headquartered company that designs, develops, manufactures, and sells automated test systems and robotics products, operating across the United States, Asia Pacific, Europe, the Middle East, and Africa. Founded in 1960 and based in North Reading, Massachusetts, Teradyne is classified within the Semiconductor Materials & Equipment sub-industry, a capital-intensive sector whose demand is closely tied to global semiconductor manufacturing cycles and capital spending by chip producers.
The company reports through three segments: Semiconductor Test, Robotics, and Other. The Semiconductor Test segment provides wafer-level, device-package, and system-level testing equipment for automotive, industrial, communications, consumer, smartphone, cloud, computing, and electronic gaming applications, with platforms such as FLEX, J750, Magnum, and ETS serving integrated device manufacturers, fabless companies, foundries, and assembly/test subcontractors. Semiconductor test equipment plays a critical role in verifying chip functionality and yield, making it a required step before devices reach end markets.
The Robotics segment supplies collaborative robotic arms and autonomous mobile robots to manufacturing, logistics, and industrial customers, positioning Teradyne in the growing industrial automation market. The Other segment covers defense/aerospace test, circuit-board test, wireless test systems, and silicon photonics testing. Teradyne also maintains a strategic collaboration with Tokyo Electron Limited to develop a test cell solution targeting AI and data center device screening applications.
- AI test demand expands via Tokyo Electron partnership
- China smartphone weakness pressures volume Semi Test revenue
- Robotics segment growth slows on industrial automation capex pullback
| Net Income: 1.37b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.19 > 0.02 and ΔFCF/TA 7.28 > 1.0 |
| NWC/Revenue: 28.97% < 20% (prev 26.41%; Δ 2.56% < -1%) |
| CFO/TA 0.24 > 3% & CFO 1.33b > Net Income 1.37b |
| Net Debt (-229.3m) to EBITDA (1.79b): -0.13 < 3 |
| Current Ratio: 2.08 > 1.5 & < 3 |
| Outstanding Shares: last quarter (157.5m) vs 12m ago -1.00% < -2% |
| Gross Margin: 59.32% > 18% (prev 58.92%; Δ 0.40% > 0.5%) |
| Asset Turnover: 106.3% > 50% (prev 72.14%; Δ 34.11% > 0%) |
| Interest Coverage Ratio: 241.4 > 6 (EBIT TTM 1.65b / Interest Expense TTM 6.85m) |
| A: 0.27 (Total Current Assets 2.79b - Total Current Liabilities 1.34b) / Total Assets 5.45b |
| B: 0.14 (Retained Earnings 744.4m / Total Assets 5.45b) |
| C: 0.35 (EBIT TTM 1.65b / Avg Total Assets 4.71b) |
| D: 2.15 (Book Value of Equity 3.69b / Total Liabilities 1.71b) |
| Altman-Z'' = 6.81 = AAA |
| DSRI: 1.07 (Receivables 1.11b/593.8m, Revenue 5.00b/2.86b) |
| GMI: 0.99 (GM 58.92% / 59.32%) |
| AQI: 0.85 (AQ_t 0.34 / AQ_t-1 0.40) |
| SGI: 1.75 (Revenue 5.00b / 2.86b) |
| TATA: 0.01 (NI 1.37b - CFO 1.33b) / TA 5.45b) |
| Beneish M = -2.52 (Cap -4..+1) = A |
As of November 03, 2026, the stock is trading at USD 261.01 with a total of 5,211,339 shares traded. Over the past week, the price has changed by -15.53%, over one month by -41.87%, over three months by -28.62% and over the past year by +42.85%.
Current recommended Stop Loss: 233.60 (which is 10.5% or 1.2 ATR below the current price).
Teradyne has received a consensus analysts rating of 4.35. Therefore, it is recommended to buy TER.
- StrongBuy: 11
- Buy: 1
- Hold: 5
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 445.5 | 70.7% |
P/E Trailing = 44.4312
P/E Forward = 24.8756
P/S = 10.9704
P/B = 14.7227
P/EG = 0.5924
Revenue TTM = 5.00b USD
EBIT TTM = 1.65b USD
EBITDA TTM = 1.79b USD
Long Term Debt = 120.1m USD (estimated: total debt 137.1m - short term 17.1m)
Short Term Debt = 17.1m USD (from shortTermDebt, last quarter)
Debt = 237.2m USD (from shortLongTermDebtTotal, last quarter) + Leases 100.1m
Net Debt = -229.3m USD (calculated: Debt 237.2m - CCE 466.6m)
Enterprise Value = 48.7b USD (49.0b + Debt 237.2m - CCE 466.6m)
Interest Coverage Ratio = 241.4 (Ebit TTM 1.65b / Interest Expense TTM 6.85m)
EV/FCF = 47.56x (Enterprise Value 48.7b / FCF TTM 1.02b)
FCF Yield = 2.10% (FCF TTM 1.02b / Enterprise Value 48.7b)
FCF Margin = 20.49% (FCF TTM 1.02b / Revenue TTM 5.00b)
Net Margin = 27.46% (Net Income TTM 1.37b / Revenue TTM 5.00b)
Gross Margin = 59.32% ((Revenue TTM 5.00b - Cost of Revenue TTM 2.03b) / Revenue TTM)
Gross Margin QoQ = 59.06% (prev 59.79%)
Tobins Q-Ratio = 8.94 (Enterprise Value 48.7b / Total Assets 5.45b)
Interest Expense / Debt = 2.89% (Interest Expense 6.85m / Debt 237.2m)
Taxrate = 13.71% (219.9m / 1.60b)
NOPAT = 1.43b (EBIT 1.65b * (1 - 13.71%))
Current Ratio = 2.08 (Total Current Assets 2.79b / Total Current Liabilities 1.34b)
Debt / Equity = 0.06 (Debt 237.2m / totalStockholderEquity, last quarter 3.69b)
Debt / EBITDA = -0.13 (Net Debt -229.3m / EBITDA 1.79b)
Debt / FCF = -0.22 (Net Debt -229.3m / FCF TTM 1.02b)
Total Stockholder Equity = 3.27b (last 4 quarters mean from totalStockholderEquity)
RoA = 29.17% (Net Income 1.37b / Total Assets 5.45b)
RoE = 42.04% (Net Income TTM 1.37b / Total Stockholder Equity 3.27b)
RoCE = 48.81% (EBIT 1.65b / Capital Employed (Equity 3.27b + L.T.Debt 120.1m))
RoIC = 36.80% (NOPAT 1.43b / Invested Capital 3.87b)
WACC = 15.58% (E(49.0b)/V(49.2b) * Re(15.64%) + D(237.2m)/V(49.2b) * Rd(2.89%) * (1-Tc(0.14)))
Discount Rate = 15.64% (= CAPM, Blume Beta Adj.) -> capped to 12.54%
Shares (quarterly) Correlation: -95.34 | Cagr: -1.64%
[DCF] Terminal Value 58.14% ; FCFF base≈797.6m ; Y1≈914.4m ; Y5≈1.35b
[DCF] Fair Price = 57.74 (EV 8.80b - Net Debt -229.3m = Equity 9.03b / Shares 156.3m; r=15.58% [WACC]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: 84.77 | EPS CAGR: 46.07% | SUE: 1.33 | # QB: 5
Revenue Correlation: 86.16 | Revenue CAGR: 22.79% | SUE: 0.76 | # QB: 0
EPS current Quarter (2027-03-31): EPS=2.48 | Chg30d=-1.01% | Revisions=+44% | Analysts=11
EPS current Year (2026-12-31): EPS=9.22 | Chg30d=+1.28% | Revisions=+84% | GrowthEPS=+132.7% | GrowthRev=+62.3%
EPS next Year (2027-12-31): EPS=11.43 | Chg30d=+0.57% | Revisions=+74% | GrowthEPS=+24.0% | GrowthRev=+23.5%
[Analyst] Revisions Ratio: +77% (up=41, down=4)